Meridian Wealth Partners’s AtriCure ATRC Stock Holding History

Meridian Wealth Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	–	–	180
2021 Q1	$0	Buy	+7	New	+$431	﹤0.01%	1331

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Meridian Wealth Partners's ATRC Position: Q2 2021 in Review

Meridian Wealth Partners sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 7 shares.

Meridian Wealth Partners first reported a position in ATRC in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

Meridian Wealth Partners reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 7 AtriCure shares in Q2 2021.
Meridian Wealth Partners first reported a position in AtriCure in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's AtriCure position peaked at $0 in Q1 2021.
212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.